Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01420263 · ClinicalTrials.gov registry record · NA

Re-feeding Gastric Residuals in Preterm Infants

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT01420263 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01420263, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether re-feeding of gastric residuals reduces the time needed to establish full enteral feedings in premature infants. Infants with gestational ages 23-28 weeks at birth will be randomized within one week to receive either gastric residuals or fresh formula or breastmilk whenever significant residuals during feeding advancement require clinical assessment for continuing feedings. Primary outcome measure is time to establish full enteral feedings (120cc/kg/day).

Interventions

  • PROCEDURE Re-feeding residuals
  • PROCEDURE Fresh Feeding Breastmilk or Formula only

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2011-08
Est. Completion 2013-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01420263

The ClinicalTrials.gov registry entry for NCT01420263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Re-feeding residuals is the first listed.

NCT01420263 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01420263 about?

NCT01420263 is a clinical study titled "Re-feeding Gastric Residuals in Preterm Infants". The purpose of this study is to determine whether re-feeding of gastric residuals reduces the time needed to establish full enteral feedings in premature infants. Infants with gestational ages 23-28 weeks at birth will be randomized within one week to receive either gastric residuals or fresh formul...

What is the current status of trial NCT01420263?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2011-08. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01420263?

The interventions under investigation include: Re-feeding residuals (PROCEDURE), Fresh Feeding Breastmilk or Formula only (PROCEDURE).

Who is sponsoring clinical trial NCT01420263?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.